中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 9
Sep.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(9): 1796-1801

Risk factors for unplanned readmission after transjugular intrahepatic portosystemic shunt in cirrhotic patients with esophagogastric variceal bleeding and construction of a nomogram model

DOI: 10.12449/JCH240913

  • Department of Gastroenterology，Affiliated Drum Tower Hospital of Nanjing University Medical School，Nanjing 210008，China

Research funding:

National Natural Science Found of China (82100652);

Affiliated Drum Tower Hospital of Nanjing University Medical School Nursing Research Project (ZSA796-1)

More Information
  • Corresponding author: WANG Qian， 523199780@qq.com （ORCID： 0009-0003-8598-1169）
  • Received Date: 2024-01-15
  • Accepted Date: 2024-04-11
  • Published Date: 2024-09-25
    Abstract
  •   Objective  To investigate the risk factors for unplanned readmission within 30 days after discharge in cirrhotic patients with esophagogastric variceal bleeding undergoing transjugular intrahepatic portosystemic shunt （TIPS）， and to construct a nomogram predictive model.  Methods  A total of 241 cirrhotic patients who underwent TIPS due to esophagogastric variceal bleeding in Affiliated Drum Tower Hospital of Nanjing University Medical School from January 2020 to June 2023 were enrolled as subjects， and unplanned readmission within 30 days was analyzed. According to the presence or absence of unplanned readmission， they were divided into readmission group with 36 patients and non-readmission group with 198 patients， and related clinical data were collected from all patients. The independent-samples t test was used for comparison of normally distributed continuous data between two groups， and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups； the chi-square test was used for comparison of categorical data between two groups. A logistic regression analysis was used to identify independent risk factors for unplanned readmission. A nomogram prediction model was constructed， and the receiver operating characteristic （ROC） curve was plotted to assess its discriminatory ability for unplanned readmission； the calibration curve was plotted to evaluate the consistency of the nomogram model in predicting unplanned readmission； the ResourceSelection package of R language was used for the Hosmer-Lemeshow goodness-of-fit test to evaluate the degree of fitting of the mode； the decision curve analysis was used to investigate the practicality of the model.  Results  Age （odds ratio ［OR］=2.664， 95% confidence interval ［CI］： 1.139‍ ‍—‍ ‍6.233， P<0.05）， CTP score （OR=1.655， 95%CI： 1.098‍ ‍—‍ ‍2.495， P<0.05）， and blood ammonia （OR=1.032， 95%CI： 1.016‍ ‍—‍ ‍1.048， P<0.05） were independent risk factors for unplanned readmission within 30 days after discharge in the patients undergoing TIPS. The multivariate analysis showed that for the nomogram predictive model constructed in this study， repeated sampling for 1 000 times using the Bootstrap method was performed for internal validation， and the area under the ROC curve was 0.773， which was significantly higher than that of age （0.582）， CTP score （0.675）， and blood ammonia （0.641）. The calibration curve showed good consistency between the probability of unplanned readmission predicted by the nomogram model and the actual probability， and the Hosmer-Lemeshow goodness-of-fit test showed good degree of fitting （c2 =5.647 3， P=0.686 7）.  Conclusion  Age， CTP score， and blood ammonia are independent risk factors for unplanned readmission within 30 days after TIPS， and the nomogram prediction model constructed based on these factors can help to predict the risk of unplanned readmission in TIPS patients and provide an accurate decision-making basis for early prevention.

     

    • FullText(HTML)
  • loading
    • References(23)
  • [1]
    BOIKE JR, THORNBURG BG, ASRANI SK, et al. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension[J]. Clin Gastroenterol Hepatol, 2022, 20( 8): 1636- 1662. e 36. DOI: 10.1016/j.cgh.2021.07.018.
    [2]
    de FRANCHIS R, BAVENO VI FACULTY. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63( 3): 743- 752. DOI: 10.1016/j.jhep.2015.05.022.
    [3]
    LYU Y, FAN DM, HAN GH. Application status and future prospect of transjugular intrahepatic portosystemic shunt in gastroesophageal variceal bleeding in liver cirrhosis[J]. J Clin Hepatol, 2022, 38( 6): 1229- 1233. DOI: 10.3969/j.issn.1001-5256.2022.06.004.

    吕勇, 樊代明, 韩国宏. 经颈静脉肝内门体分流术在肝硬化食管胃底静脉曲张破裂出血中的应用现状与未来展望[J]. 临床肝胆病杂志, 2022, 38( 6): 1229- 1233. DOI: 10.3969/j.issn.1001-5256.2022.06.004.
    [4]
    ZHANG K, LIU JL, LIU YL, et al. To observe the clinical effect of transjugular intrahepatic portosystemic shunt guided by 3D model constructed by CT thin-layer scanning data computer in the treatment of cirrhotic portal hypertension complicated with gastrointestinal bleeding[J]. Clin J Med Offic, 2023, 51( 6): 655- 656, 660. DOI: 10.16680/j.1671-3826.2023.06.28.

    张凯, 刘晶磊, 刘燚隆, 等. 应用CT薄层扫描数据电脑构建3D模型指导经颈静脉肝内门体分流术治疗肝硬化门脉高压合并消化道出血临床效果观察[J]. 临床军医杂志, 2023, 51( 6): 655- 656, 660. DOI: 10.16680/j.1671-3826.2023.06.28.
    [5]
    CHEN GH, WANG GC, ZHANG CQ. Current status of research on hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol, 2021, 37( 5): 1201- 1204. DOI: 10.3969/j.issn.1001-5256.2021.05.047.

    陈功海, 王广川, 张春清. 经颈静脉肝内门体分流术后肝性脑病的研究现状[J]. 临床肝胆病杂志, 2021, 37( 5): 1201- 1204. DOI: 10.3969/j.issn.1001-5256.2021.05.047.
    [6]
    FENG LJ, WANG Y, JIA JD. Clinical management of common complications of liver cirrhosis[J]. Chin Hepatol, 2023, 28( 1): 13- 16. DOI: 10.14000/j.cnki.issn.1008-1704.2023.01.033.

    冯丽娟, 王宇, 贾继东. 肝硬化常见并发症的临床管理[J]. 肝脏, 2023, 28( 1): 13- 16. DOI: 10.14000/j.cnki.issn.1008-1704.2023.01.033.
    [7]
    The Chinese College of Interventionalists. CCI clinical practice guidelines: Management of TIPS for portal hypertension(2019 edition)[J]. J Clin Hepatol, 2019, 35( 12): 2694- 2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.

    中国医师协会介入医师分会. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35( 12): 2694- 2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.
    [8]
    ZHOU NS, ZHANG J, MA XM, et al. The study of unplanned readmission within 31 days after being discharged in one general third-level grade A hospital in Beijing[J]. Chin Hosp Manag, 2010, 30( 4): 18- 20. DOI: 10.3969/j.issn.1001-5329.2010.04.008.

    周念松, 张俊, 马谢民, 等. 北京市某三甲医院31天内非计划性再入院研究[J]. 中国医院管理, 2010, 30( 4): 18- 20. DOI: 10.3969/j.issn.1001-5329.2010.04.008.
    [9]
    General Office of the Ministry of Health. Notice on printing and distributing the indicators of medical quality management and control in tertiary general hospitals(2011 edition)[EB/OL].( 2011-01-27)[ 2023-11-10]. http://www.gov.cn/gzdt/2011-01/27/content_1793358.htm. http://www.gov.cn/gzdt/2011-01/27/content_1793358.htm

    卫生部办公厅. 关于印发《三级综合医院医疗质量管理与控制指标(2011年版)》的通知[EB/OL].( 2011-01-27)[ 2023-11-10]. http://www.gov.cn/gzdt/2011-01/27/content_1793358.htm. http://www.gov.cn/gzdt/2011-01/27/content_1793358.htm
    [10]
    HAN Q. Analysis of types of diseases, days of interval and influencing factors of unplanned re-admission patients within 31 days after discharge[J]. Chin Nurs Res, 2020, 34( 16): 2862- 2867. DOI: 10.12102/j.issn.1009-6493.2020.16.010.

    韩祺. 出院31 d内非计划再入院病人疾病种类、间隔天数与影响因素分析[J]. 护理研究, 2020, 34( 16): 2862- 2867. DOI: 10.12102/j.issn.1009-6493.2020.16.010.
    [11]
    SARWAR A, WEINSTEIN JL, NOVACK V, et al. Causes and rates of 30-day readmissions after transjugular intrahepatic portosystemic shunts[J]. AJR Am J Roentgenol, 2020, 215( 1): 235- 241. DOI: 10.2214/AJR.19.21732.
    [12]
    SHENG S, HUANG Y. Establishment and validation of the interactive nomogram model for all-cause readmission within 90-days in patients with heart failure[J]. Chin J Integr Med Cardio Cerebrovasc Dis, 2023, 21( 16): 2909- 2915. DOI: 10.12102/j.issn.1672-1349.2023.16.002.

    盛松, 黄烨. 心力衰竭病人90 d内再入院的交互式列线图模型建立与验证[J]. 中西医结合心脑血管病杂志, 2023, 21( 16): 2909- 2915. DOI: 10.12102/j.issn.1672-1349.2023.16.002.
    [13]
    CHEN XY, LI K, WANG X, et al. Establishment of prediction model of unplanned readmission within 30 days after discharge in elderly patients receiving total knee arthroplasty[J]. Pract Geriatr, 2023, 37( 8): 772- 776. DOI: 10.3969/j.issn.1003-9198.2023.08.005.

    陈翔宇, 李凯, 王旭, 等. 老年病人行全膝关节置换术出院后30天内非计划再入院预测模型的建立[J]. 实用老年医学, 2023, 37( 8): 772- 776. DOI: 10.3969/j.issn.1003-9198.2023.08.005.
    [14]
    MA L, WANG ZX, LUO B. Predictive value of HALP index for unplanned readmission within 30 days after discharge in elderly patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Pract J Card Cereb Pneumal Vasc Dis, 2024, 32( 2): 20- 23. DOI: 10.12114/j.issn.1008-5971.2024.00.028.

    马玲, 王志贤, 罗兵. HALP指数对老年慢性阻塞性肺疾病急性加重期患者出院后30 d内非计划再入院的预测价值[J]. 实用心脑肺血管病杂志, 2024, 32( 2): 20- 23. DOI: 10.12114/j.issn.1008-5971.2024.00.028.
    [15]
    ZHANG JQ, WANG ZC, YANG JY, et al. Construction and validation of the risk prediction model for secondary hepatic encephalopathy in patients with chronic hepatitis B and cirrhosis[J]. Chin Hepatol, 2023, 28( 8): 916- 920, 931. DOI: 10.14000/j.cnki.issn.1008-1704.2023.08.011.

    张家齐, 王再超, 杨家耀, 等. 慢性乙型肝炎肝硬化患者继发肝性脑病风险预测模型的构建与验证[J]. 肝脏, 2023, 28( 8): 916- 920, 931. DOI: 10.14000/j.cnki.issn.1008-1704.2023.08.011.
    [16]
    PUGH RN, MURRAY-LYON IM, DAWSON JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60( 8): 646- 649. DOI: 10.1002/bjs.1800600817.
    [17]
    LI H, XIA ZB, XIAO NJ, et al. Current research status of prognostic models for transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol, 2023, 39( 5): 1191- 1196. DOI: 10.3969/j.issn.1001-5256.2023.05.030.

    李慧, 夏志波, 肖年军, 等. 经颈静脉肝内门体分流术预后模型的研究现状[J]. 临床肝胆病杂志, 2023, 39( 5): 1191- 1196. DOI: 10.3969/j.issn.1001-5256.2023.05.030.
    [18]
    LIU ZL, FAN ZP, LIU YL, et al. Value of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score in predicting the prognosis of patients with hepatic sinus obstruction syndrome associated with Gynura segetum(Lour.) Merr[J]. J Clin Hepatol, 2020, 36( 11): 2462- 2466. DOI: 10.3969/j.issn.1001-5256.2020.11.013.

    刘贞利, 范作鹏, 柳雅立, 等. 终末期肝病模型及CTP评分系统对土三七相关肝窦阻塞综合征患者预后的预测价值[J]. 临床肝胆病杂志, 2020, 36( 11): 2462- 2466. DOI: 10.3969/j.issn.1001-5256.2020.11.013.
    [19]
    ZHANG F, LIU B, SHI YQ, et al. Analysis of risk factors for hepatic encephalopathy in patients with liver cirrhosis with upper gastrointestinal bleeding[J]. Chin J Integr Tradit West Med Dig, 2018, 26( 11): 934- 937. DOI: 10.3969/j.issn.1671-038X.2018.11.10.

    张飞, 刘斌, 施彦卿, 等. 肝硬化上消化道出血患者并发肝性脑病的危险因素分析[J]. 中国中西医结合消化杂志, 2018, 26( 11): 934- 937. DOI: 10.3969/j.issn.1671-038X.2018.11.10.
    [20]
    LOCKWOOD AH. Blood ammonia levels and hepatic encephalopathy[J]. Metab Brain Dis, 2004, 19( 3-4): 345- 349. DOI: 10.1023/b: mebr.0000043980.74574.eb.
    [21]
    VILSTRUP H, AMODIO P, BAJAJ J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J]. Hepatology, 2014, 60( 2): 715- 735. DOI: 10.1002/hep.27210.
    [22]
    BROWN JR, ALONSO A, MAZIMBA S, et al. Improved 30 day heart failure rehospitalization prediction through the addition of device-measured parameters[J]. ESC Heart Failure, 2020, 7( 6): 3762- 3771. DOI: 10.1002/ehf2.12956.
    [23]
    GLANCE LG, KELLERMANN AL, OSLER TM, et al. Hospital readmission after noncardiac surgery: the role of major complications[J]. JAMA Surg, 2014, 149( 5): 439- 445. DOI: 10.1001/jamasurg.2014.4.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (162) PDF downloads(32) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return